Japan Vietnam Medical Instrument JSC (VN:JVC) — Stock Price

₫3060.00 VND
▲ 0.33% today

Japan Vietnam Medical Instrument JSC (VN:JVC) is currently trading at ₫3060.00 VND, up 0.33% today. Over the past 52 weeks, shares have ranged between ₫2970.00 and ₫9000.00. This page tracks Japan Vietnam Medical Instrument JSC's live share price on the VN exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see how much is Japan Vietnam Medical Instrument JSC worth.

Japan Vietnam Medical Instrument JSC (JVC) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Japan Vietnam Medical Instrument JSC's daily closing share price and trading volume on the VN exchange over the past year, giving a clear view of recent price momentum and liquidity.

Japan Vietnam Medical Instrument JSC Income Statement — Revenue, Profit & Earnings by Year

Japan Vietnam Medical Instrument JSC's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 202220212020
Total Revenue ₫391.23 Billion ₫411.42 Billion ₫517.17 Billion
Cost of Revenue ₫350.70 Billion ₫375.56 Billion ₫408.12 Billion
Gross Profit ₫40.53 Billion ₫35.85 Billion ₫109.06 Billion
Research & Development
SG&A ₫36.63 Billion ₫51.92 Billion ₫71.31 Billion
Total Operating Expenses ₫429.38 Billion ₫486.33 Billion ₫528.99 Billion
Operating Income ₫-38.15 Billion ₫-74.91 Billion ₫-11.82 Billion
EBITDA ₫58.67 Billion ₫31.76 Billion ₫80.94 Billion
EBIT
Interest Expense ₫4.32 Billion ₫1.21 Billion ₫9.04 Million
Income Before Tax ₫-29.45 Billion ₫-76.58 Billion ₫2.73 Billion
Income Tax Expense
Net Income ₫-29.94 Billion ₫-76.69 Billion ₫2.80 Billion

Japan Vietnam Medical Instrument JSC Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Japan Vietnam Medical Instrument JSC's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 202220212020
Total Assets ₫600.53 Billion ₫627.73 Billion ₫637.86 Billion
Total Current Assets ₫321.08 Billion ₫300.32 Billion ₫318.53 Billion
Cash & Equivalents
Short-term Investments ₫180.00 Million ₫11.00 Billion
Net Receivables ₫421.72 Billion ₫486.28 Billion ₫498.84 Billion
Inventory ₫70.79 Billion ₫60.07 Billion ₫123.16 Billion
Property, Plant & Equipment
Goodwill
Total Liabilities ₫175.55 Billion ₫173.03 Billion ₫106.48 Billion
Total Current Liabilities ₫164.59 Billion ₫156.44 Billion ₫81.70 Billion
Long-term Debt ₫2.20 Billion ₫3.98 Billion
Net Debt
Total Stockholder Equity ₫424.75 Billion ₫454.69 Billion ₫531.38 Billion
Retained Earnings ₫-1.12 Trillion ₫-1.09 Trillion ₫-1.02 Trillion

Japan Vietnam Medical Instrument JSC Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Japan Vietnam Medical Instrument JSC generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20222021202020172016
Operating Cash Flow ₫42.10 Billion ₫127.02 Billion ₫30.71 Billion ₫76.13 Billion ₫-319.02 Billion
Capital Expenditures ₫31.38 Billion ₫40.81 Billion ₫22.45 Billion ₫42.59 Billion ₫8.81 Billion
Free Cash Flow ₫10.73 Billion ₫86.21 Billion ₫8.25 Billion
Investing Cash Flow ₫-38.62 Billion ₫177.66 Billion
Financing Cash Flow ₫-15.89 Billion ₫-346.36 Billion
Dividends Paid
Stock-Based Compensation
Depreciation ₫83.80 Billion ₫107.13 Billion ₫78.20 Billion ₫69.64 Billion ₫75.24 Billion
Change in Cash ₫3.78 Billion ₫-33.74 Billion ₫-433.14 Million ₫21.62 Billion ₫-487.72 Billion

Japan Vietnam Medical Instrument JSC Earnings History — EPS Actual vs. Analyst Estimates

Track Japan Vietnam Medical Instrument JSC's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Mar 31, 2026 100.94
Dec 31, 2025 87.66
Sep 30, 2025 109.23
Jun 30, 2025 27.58
Mar 31, 2025 217.25
Feb 26, 2025 248.24
Nov 27, 2024 74.98
Aug 28, 2024 82.41